“…The beta-lactam class of antibiotics has not been used in the treatment of M.tb or other mycobacterial infections as mycobacteria are resistant to these antibiotics and produce betalactamases (Kasik, 1979;Kwon et al, 1995). However, the effectiveness of beta-lactam/beta-lactamase inhibitor combinations has been shown in-vitro for M.tb (Chambers et al, 1995), and also in clinical settings of TB (Chambers et al, 1998;Cynamon et al, 1983;Segura et al, 1998;Sorg and Cynamon, 1987), M. avium (Casal et al, 1987), and M. smegmatis (Yabu et al, 1985). Rv0908 (ctpE), which codes for putative cation transporter, is also present in the same operon.…”